search

Active clinical trials for "Pituitary Diseases"

Results 161-170 of 184

Evaluation of Early Retinal Vascular Modifications After Endoscopic Endonasal Pituitary Surgery...

Pituitary Adenoma

This study evaluates the retinal vascular features using optical coherence tomography angiography in patients that received endoscopic endonasal approach for the removal of an intra-suprasellar pituitary adenoma compressing the optic nerve.

Completed10 enrollment criteria

Predictive OCTA Biomarkers After Endoscopic Endonasal Pituitary Surgery

Pituitary Adenoma

This study evaluates the structural parameters, by spectral domain optical coherence tomography (OCT), retinal vessel density, using OCT angiography, and visual acuity in patients that received endoscopic endonasal approach for the removal of an intra-suprasellar pituitary adenoma compressing the optic nerve.

Completed10 enrollment criteria

Changes in the Hypotalamic-pituitary Region of Patients With Metabolic Syndrome and Obesity

Overweight and ObesityMetabolic Syndrome

This study aims to identify new morphological and quantitative magnetic imaging parameters of pituitary gland and sellar region in overweight and obese patient at baseline and after 3 years, dividing patients in 3 groups (weight loss through diet and lifestyle changes, weight loss through bariatric surgery, no weight loss)

Completed6 enrollment criteria

Forces During Skull Base Surgery

Skull BasePituitary3 more

This study is designed to measure forces applied using standard surgical instruments at the skull base during resection of skull base lesions. This data will be useful for optimizing an active canula robot for assisting in skull base surgery. We hypothesize that through measurement of forces generated during routine endoscopic skull base surgery we will be able to optimize the canulas of an active canula robot for skull base surgery.

Completed3 enrollment criteria

PITUItary Carcinoma or Aggressive Tumors REgistry -Lyon

Pituitary Tumor

The purpose of this study is to observe predictors of pituitary tumor recurrence and markers of persistent disease activity through computerized collection of comprehensive demographic, therapeutic, pathologic and outcome information on patients harboring pituitary mass lesions of all types.

Unknown status2 enrollment criteria

Hepatic Steatosis and Pituitary Gland Failure, Evaluation by Nuclear Magnetic Resonance (NMR) Imaging...

Hepatic SteatosisPituitary Gland Failure

The investigator put forward the hypothesis that liver fat mass in patients with pituitary gland failure is greater than that in a control population. Failure of the anterior pituitary and more particularly impaired production of growth hormone (GH) could be the principal mechanism responsible for increased liver fat mass in these patients.

Unknown status12 enrollment criteria

Postoperative Cognitive Dysfunction in Patients Undergoing Pituitary Removal Surgery

Pituitary Tumor

As postoperative cognitive dysfunction rates are high especially in elder patients, cognitive dysfunction is not diagnosed and treated effectively. This statement is associated with prolonged hospital stays by increasing morbidity. We wanted to see the incidency of postoperative cognitive dysfunction in patients undergoing elective pituitary tumor removal surgery.

Unknown status6 enrollment criteria

Incidence of Rhinological Morbidities During Endonasal Pituitary Surgery, With or Without Nasoseptal...

Surgery--Complications

Determine and compare prospectively the incidence of rhinological adverse events during pituitary surgery with or without nasoseptal flap

Unknown status8 enrollment criteria

Does Topical Steroid Treatment Impair the Adrenal Function?

Hypothalamus-Pituitary-Adrenal Axis AssessementTopical Steroid Therapy in Chronic Skin Diseases

The purpose of this study is to determine if topical steroids treatment for different skin diseases suppress the adrenal cortisol production.

Unknown status4 enrollment criteria

Heart Rate Variability (HRV) in Pituitary Adenoma

Pituitary Adenoma

Several studies have been reported that heart rate is known to be associated with prognosis in chronic diseases and acute diseases. For example, a decrease in heart rate following myocardial infarction may lead to a higher mortality rate. It is also known to predict heart failure, diabetic neuropathy, and even depression. The combined pituitary function test artificially induces hypoglycemia to observe the secretion of pituitary hormone. The degree of change in heart rate during hypoglycemia can predict the adequacy of the test, and heart rate can be changed according to the characteristic of the tumor. Also, the prognosis can be predicted based on this. In our study, we used a licensed device approved by KFDA (Korea Food and Drug Administration) to measure heart rate variability in patients with pituitary adenoma.

Unknown status9 enrollment criteria
1...16171819

Need Help? Contact our team!


We'll reach out to this number within 24 hrs